FDA Slide 16 & Table 2: Everything Being Reported to VAERS
First published July 2, 2021 Post Edited September 20, 2022 to include updates. At the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on October 22, 2020 Meeting, Steve Anderson, PhD, MPPDirector, Office of Biostatistics & Epidemiology, Center for Biologics Evaluation and Research (CBER) gave a presentation on CBER “Plans for Monitoring COVID-19 Vaccine Safety […]
FDA Slide 16 & Table 2: Everything Being Reported to VAERS Read More »